UK medical watchdog rejects 1st drug to extend lives for patients with advanced skin cancer

October 17, 2011

An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer is too expensive to be used by the U.K.’s health care system, a recommendation critics called a potential death sentence. (Washington Post)